Overview

Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
Zonisamide (Zonegran) and sodium valproate (Epilim) are both medicines approved to treat epilepsy. The purpose of this study is to find out the extent to which zonisamide may affect memory and concentration, compared to sodium valproate.
Phase:
Phase 4
Details
Lead Sponsor:
Eisai Limited
Treatments:
Valproic Acid
Zonisamide